•1 min read•from Science News
An unproven autism drug got a boost after a White House briefing
In fall of 2025, the Trump administration touted the drug leucovorin for autism therapy without new evidence. Dispensing of the drug to kids rose.
Want to read more?
Check out the full article on the original site
Tagged with
#autism
#leucovorin
#drug
#therapy
#administration
#Trump administration
#White House
#evidence
#dispensing
#kids
#pharmaceutical
#treatment
#clinical trial
#healthcare
#2025
#medical
#pediatrics
#neurology
#public health
#policy